Corentec Co Ltd (104540) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.100x

Based on the latest financial reports, Corentec Co Ltd (104540) has a cash flow conversion efficiency ratio of 0.100x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.50 Billion ≈ $5.76 Million USD) by net assets (₩85.14 Billion ≈ $57.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Corentec Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Corentec Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Corentec Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 104540 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Corentec Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Corentec Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ROCA INDUSTRY HOLDINGROCK1 S.A.
RO:ROC1
N/A
Network-1 Technologies Inc
NYSE MKT:NTIP
-0.003x
Risma Systems AS
CO:RISMA
0.209x
Dr Peng Telecom and Media Group Co Ltd
SHG:600804
-0.566x
Gol Linhas Aéreas Inteligentes S.A
NYSE:GOLLQ
-0.024x
Take Solutions Limited
NSE:TAKE
-0.122x
DOREL INDS INC. B
F:DO4B
0.485x
Dacome International Ltd
TWO:9960
0.076x

Annual Cash Flow Conversion Efficiency for Corentec Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Corentec Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Corentec Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩71.98 Billion
≈ $48.78 Million
₩-6.61 Billion
≈ $-4.48 Million
-0.092x -400.04%
2023-12-31 ₩86.12 Billion
≈ $58.36 Million
₩2.63 Billion
≈ $1.79 Million
0.031x -81.03%
2022-12-31 ₩65.75 Billion
≈ $44.56 Million
₩10.60 Billion
≈ $7.18 Million
0.161x +124.02%
2021-12-31 ₩56.63 Billion
≈ $38.38 Million
₩4.08 Billion
≈ $2.76 Million
0.072x +192.57%
2020-12-31 ₩46.41 Billion
≈ $31.45 Million
₩-3.61 Billion
≈ $-2.44 Million
-0.078x -160.37%
2019-12-31 ₩29.94 Billion
≈ $20.29 Million
₩3.86 Billion
≈ $2.61 Million
0.129x -41.02%
2018-12-31 ₩24.09 Billion
≈ $16.32 Million
₩5.26 Billion
≈ $3.56 Million
0.218x +102.32%
2017-12-31 ₩54.32 Billion
≈ $36.81 Million
₩5.86 Billion
≈ $3.97 Million
0.108x +120.77%
2016-12-31 ₩60.18 Billion
≈ $40.79 Million
₩2.94 Billion
≈ $1.99 Million
0.049x +8.09%
2015-12-31 ₩56.27 Billion
≈ $38.13 Million
₩2.54 Billion
≈ $1.72 Million
0.045x +384.68%
2014-12-31 ₩48.30 Billion
≈ $32.73 Million
₩450.70 Million
≈ $305.43K
0.009x -60.24%
2013-12-31 ₩44.48 Billion
≈ $30.15 Million
₩1.04 Billion
≈ $707.46K
0.023x --

About Corentec Co Ltd

KQ:104540 Korea Medical Devices
Market Cap
$33.88 Million
₩49.99 Billion KRW
Market Cap Rank
#23277 Global
#1530 in Korea
Share Price
₩3910.00
Change (1 day)
+1.16%
52-Week Range
₩3720.00 - ₩7160.00
All Time High
₩18150.00
About

Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more